Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...
With truckloads of trash juice laden with toxic PFAS arriving at its facility, a wastewater treatment plant in North Conway ...
Gene therapy that can cross the blood–brain barrier represents a non-invasive way to map gene expression in the brains of ...
Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.
The microbes in the human gastrointestinal tract can exert a strong influence on our bodies, in part by creating and ...
Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...
Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...
Dwarfing every living thing around them millions of years ago, Prototaxites have long defied scientific classification ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule ...
TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsRoopal Thakkar - Executive VP of Research ...
On the occasion of International Women's Day, Outlook Business in an exclusive interview features Saloni Anand, co-founder of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results